Navigation Links
DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC

esults, performance, prospects and opportunities, including statements regarding the potential use of orBec® for the treatment of gastrointestinal GVHD and the prospects for regulatory filings for orBec®. Where possible, DOR has tried to identify these forward-looking statements by using words such as "anticipates," "believes," "intends," or similar expressions. These statements are subject to a number of risks, uncertainties and other factors that could cause actual events or results in future periods to differ materially from what is expressed in, or implied by, these statements. DOR cannot assure you that it will be able to successfully develop or commercialize products based on its technology, including orBec®, particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals, that its technologies will prove to be safe and effective, that its cash expenditures will not exceed projected levels, that it will be able to obtain future financing or funds when needed, that product development and commercialization efforts will not be reduced or discontinued due to difficulties or delays in clinical trials or due to lack of progress or positive results from research and development efforts, that it will be able to successfully obtain any further grants and awards, maintain its existing grants which are subject to performance, enter into any biodefense procurement contracts with the U.S. Government or other countries, that the U.S. Congress may not pass any legislation that would provide additional funding for the Project BioShield program, that it will be able to patent, register or protect its technology from challenge and products from competition or maintain or expand its license agreements with its current licensors, or that its business strategy will be successful. Important factors which may affect
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
2. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
5. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
6. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:10/30/2014)... Oct. 30, 2014  Electronic health records uptake ... result of government initiatives and the considerable resources ... have invested over the past five years. Electronic ... IT, and U.S. clinicians use them on a ... http://photos.prnewswire.com/prnh/20141029/155278LOGO Frost & Sullivan,s ...
(Date:10/30/2014)... WOONSOCKET, R.I. , Oct. 30, 2014 CVS ... entered into new clinical affiliations with three leading regional health ... for patients. The collaborating health systems include Baptist Health System ... affiliated hospitals which include Commonwealth Health in Pennsylvania ... Arizona , and Tennova Healthcare in ...
(Date:10/30/2014)... China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or ... in China , today announced that ... results on Wednesday, November 5, 2014 after the market ... a conference call at 7:30 a.m. Eastern Time on ... Time on November 6, 2014, to discuss third quarter ...
Breaking Medicine Technology:Electronic Health Record Usability: CIOs Weigh In 2Electronic Health Record Usability: CIOs Weigh In 3Electronic Health Record Usability: CIOs Weigh In 4CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 2CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 3CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 4China Biologic to Report Third Quarter 2014 Financial Results 2
... of a new cytokine called IL-35 could allow clinicians ... response, MEMPHIS, Tenn., Nov. 21 Investigators at ... molecule,that prevents immune responses from running amok and damaging ... new treatments for cancer, using,vaccines; for autoimmune diseases, such ...
... Nov. 20 A new study,released by Indiana ... in immediate and significant improvements in heart,health, particularly ... decrease in,hospital admissions for heart attacks, also known ... prior cardiac history in Monroe,County, Indiana versus the ...
Cached Medicine Technology:St. Jude Finds Molecule That Could Improve Cancer Vaccine and Therapy for Other Diseases 2Smokefree Workplace Law Reduces Heart Attacks 59% Among Nonsmokers, New Research Shows 2
(Date:10/31/2014)... HealthDay Reporter THURSDAY, Oct. 30, ... additional $100 million in the fight against the Ebola outbreak ... the World Bank,s total pledge to more than $500 million, ... to the three hardest-hit countries -- Guinea, Liberia and Sierra ... has increased significantly in recent weeks, but we still have ...
(Date:10/31/2014)... Oct. 30, 2014 (HealthDay News) -- Wearing masks made ... festivities that could be risky for children with asthma, ... association advises parents to be proactive about managing their ... enjoyable. Some of the steps they recommend parents ... and haunted houses are exciting adventures that can lead ...
(Date:10/31/2014)... Steven Reinberg HealthDay ... Leprosy, although quite rare, continues to appear in the United ... new cases are reported in the United States each year, ... said. That compares to about 250,000 cases that occurred worldwide ... times, leprosy is an infectious disease that causes skin sores, ...
(Date:10/31/2014)... — A new report by Milken Institute School ... George Washington University examines the challenge of maintaining ... enrolled in Covered California and who are also ... Services Program (CPSP). The CPSP, whose roots are ... ever developed for low-income pregnant women, makes enriched ...
(Date:10/30/2014)... an institutional patient registry on stereotactic body radiotherapy ... of tumors, for medically inoperable, early stage lung ... 2012, according to research presented today at the ... Symposium is sponsored by the American Society of ... Oncology (ASTRO), the International Association for the Study ...
Breaking Medicine News(10 mins):Health News:World Bank Pledges $100M More to Fight West Africa's Ebola Outbreak 2Health News: Halloween Safety Tips for Kids With Asthma 2Health News:Leprosy Still Occurs in U.S., CDC Reports 2Health News:Leprosy Still Occurs in U.S., CDC Reports 3Health News:Report examines health care challenges for pregnant women enrolled in covered California 2Health News:Sustained local control for medically inoperable, early stage lung cancer patients 2Health News:Sustained local control for medically inoperable, early stage lung cancer patients 3
... Health has awarded $10.24 million to Fred Hutchinson Cancer ... to understand and prevent breast cancer disparities in Hispanic ... nationwide to receive funding as part of the NIH ... is launching a major new effort to understand and ...
... a specific type of dopamine receptor gene respond ... without the genotype, according to new research from ... come from the first-ever placebo-controlled pharmacogenetic drug trial ... to evaluate variants of the DRD4 dopamine receptor ...
... According ... the ages of 25 and 34 report being taught to practice defensive medicine. , ... Atlanta, GA (PRWEB) May 3, 2010 -- According to ... of physicians between the ages of 25 and 34 report being taught to practice defensive medicine., ...
... ... National Lupus Awareness Month 2010 with a 115-sq-ft display window at 10 Rockefeller Plaza to ... in the heart of New York City, was generously donated by EHE International for the ... (PRWEB) ...
... Mass. -- Our DNA is under constant siege from a ... of cells to repair that damage has broad health implications, ... used to study DNA damage are quite limited, but MIT ... analysis that promises to make an impact on human health. ...
... 3, 2010) The results of new research results ... of the American College of Surgeons show that ... a hospital surgical ward. Postoperative pneumonia is ... third most common infectious complication after urinary tract and ...
Cached Medicine News:Health News:Hutchinson Center receives $10.24 million from NIH for Latina breast cancer research 2Health News:Hutchinson Center receives $10.24 million from NIH for Latina breast cancer research 3Health News:Hutchinson Center receives $10.24 million from NIH for Latina breast cancer research 4Health News:Hutchinson Center receives $10.24 million from NIH for Latina breast cancer research 5Health News:Research helps end guesswork in prescribing ADHD drug 2Health News:Young Physicians Taught to Practice Defensive Medicine, Survey Finds 2Health News:Young Physicians Taught to Practice Defensive Medicine, Survey Finds 3Health News:Lupus Awareness Month Kicks Off at Rockefeller Center: EHE International Donates Display Window to S.L.E. Lupus Foundation for May 2Health News:Lupus Awareness Month Kicks Off at Rockefeller Center: EHE International Donates Display Window to S.L.E. Lupus Foundation for May 3Health News:Rapid analysis of DNA damage now possible 2Health News:Surgeons' pilot prevention program reduces incidence of postoperative pneumonia 2
Microwell IRMA for the detection of Intact PTH...
Mircrowell EIA for detection of Intact PTH...
... Loading Units with Stainless Steel Staples for ... ,Utilizing a disposable loading unit, the LDS-2™ ... ligate the tissue within the cartridge jaw ... between the two closed clips. The instrument ...
... The Auto Suture™ Powered LDS™ single ... ligate tissue within the cartridge jaw and ... the two closed staples. , ,The ... with titanium staples have application in abdominal, ...
Medicine Products: